Immediate Impact
10 from Science/Nature 77 standout
Citing Papers
Refining the impact of genetic evidence on clinical success
2024 StandoutNature
Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
Works of Christopher Gasink being referenced
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
2012 Standout
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase2b Study of Ustekinumab, a Human Monoclonal Antibody to IL-12/23p40, in Patients With Moderately to Severely Active Crohn's Disease: Results Through Week 22 From the Certifi Trial
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher Gasink | 1698 | 577 | 1085 | 941 | 90 | 2.1k | |
| Bella Ungar | 1776 | 480 | 1321 | 962 | 86 | 2.2k | |
| Ella Fudim | 1388 | 333 | 1004 | 984 | 50 | 2.0k | |
| Fabian Schnitzler | 2295 | 823 | 1749 | 886 | 42 | 2.9k | |
| Masakazu Takazoe | 1760 | 792 | 932 | 1177 | 74 | 2.7k | |
| René Fiasse | 1039 | 644 | 1094 | 356 | 108 | 2.0k | |
| Koji Sawada | 1091 | 248 | 836 | 753 | 104 | 2.0k | |
| Per Karlén | 2398 | 899 | 1801 | 417 | 46 | 3.1k | |
| Yao He | 1101 | 671 | 818 | 311 | 95 | 1.9k | |
| Jean‐Marc Gornet | 668 | 691 | 650 | 386 | 72 | 1.8k | |
| Maria Nachury | 952 | 818 | 649 | 509 | 80 | 2.0k |
All Works
Loading papers...